Variables | Total | |
---|---|---|
n | % | |
Sex | ||
Male | 476 | 61.6 |
Female | 297 | 38.4 |
Age (years) | ||
Mean – SD | 65.2 | 16.7 |
Isolate | ||
E. coli | 246 | 31.8 |
ECN | 172 | 22.3 |
Klebsiella sp | 59 | 7.6 |
MSSA | 52 | 6.7 |
Pseudomonas aeruginosa | 27 | 3.5 |
Enterobacter. sp | 22 | 2.8 |
Proteus.sp | 20 | 2.6 |
Enterococcus faecalis | 19 | 2.5 |
Candida sp | 10 | 1.3 |
MRSA | 13 | 1.7 |
Other | 115 | 14.9 |
Streptococcus pneumoniae | 18 | 2.3 |
ESBL multi-resistance | ||
Absent | 736 | 95.2 |
Present | 37 | 4.8 |
Type of infection | ||
Community-acquired | 320 | 41.4 |
Nosocomial | 173 | 22.4 |
healthcare-associated | 280 | 36.2 |
Source of infection | ||
Absent | 63 | 8.2 |
Present | 710 | 91.8 |
Treatment modification | ||
Change to another drug | 395 | 51.1 |
Extension of duration | 28 | 3.6 |
No change | 350 | 45.3 |
McCabea | ||
NF | 337 | 43.7 |
UF | 318 | 41.2 |
RF | 117 | 15.2 |
Pitta | ||
0–2 | 643 | 83.3 |
≥ 3 | 129 | 16.7 |
Charlsona | ||
0–2 | 423 | 54.8 |
≥ 3 | 349 | 45.2 |